NewGenIvf (NIVF) Common Equity (2022 - 2025)

NewGenIvf (NIVF) has 4 years of Common Equity data on file, last reported at $26.0 million in Q4 2025.

• In Q4 2025, Common Equity rose 1853.78% year-over-year to $26.0 million; the TTM figure through Dec 2025 stood at $26.0 million (up 1853.78% YoY), while the FY2025 annual figure was $26.0 million, up 1853.78% from the prior year.
• Common Equity climbed to $26.0 million in Q4 2025, from -$1.5 million in the prior quarter.
• Across five years, Common Equity topped out at $26.0 million in Q4 2025 and bottomed at -$1.5 million in Q4 2024.
• A 4-year average of $7.0 million and a median of $1.7 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity soared 3123.54% — and 2024, when it plunged 145.65%.
• Year by year, Common Equity stood at $100683.0 in 2022, then jumped by 3123.54% to $3.2 million in 2023, then plunged by 145.65% to -$1.5 million in 2024, then surged by 1853.78% to $26.0 million in 2025.
• The last three Common Equity figures came in at $26.0 million (Q4 2025), -$1.5 million (Q4 2024), and $3.2 million (Q4 2023), per Business Quant data.

Peer Comparison